Outcomes of cancer bereavement therapeutic support groups
| ISRCTN | ISRCTN56216152 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN56216152 |
| Protocol serial number | 180829TLF |
| Sponsor | The Loss Foundation |
| Funders | The Loss Foundation, Postcode Community Trust |
- Submission date
- 31/08/2018
- Registration date
- 10/09/2018
- Last edited
- 04/06/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
The loss of a loved one to cancer is associated with negative bereavement outcomes such as higher levels of depression, anxiety, and sleep difficulties, and can place individuals at greater risk of developing complicated grief responses. People who have lost a loved one to cancer may require more than informal support provided by friends and family in order to help them adapt to their bereavement. Group bereavement interventions are a popular treatment format for bereavement support. Their popularity can be attributed to their effective use of resources, social acceptability, and therapeutic factors that often meet the needs of bereaved individuals (e.g. reducing social isolation).
Group bereavement interventions tend to be either self-help groups (sometimes referred to as mutual support groups), or more formalised therapeutic bereavement groups. Self-help groups are usually informal, self-governing, support network focused, and are usually open to anyone who has experienced a loss. Members of bereavement self-help groups report many positive aspects, such as social support, emotional expression, reciprocity within the group, exchanging of information and advice, and sharing of hope. Few studies have used objective measures to examine the effectiveness of self-help groups for cancer bereavement. The research that has been conducted presents consistent findings that participants report self-help groups as being beneficial, but changes on objective outcome measures of psychological symptoms are not found.
The second type of group intervention for bereavement are therapeutic groups, which differ from self-help groups in that they have structured content and are initiated and led by professionals. These groups are often based on theoretical knowledge and practice, and the professional facilitating the group is usually distinct from the group members. Therapeutic bereavement groups specific to a type of loss (e.g. HIV-related death) have been shown to be an effective intervention for grief reactions. Group homogeneity is associated with increased group cohesion and better outcomes.
When individuals experience the same type of bereavement there may be similar themes or symptoms in their grief reactions, which specific therapeutic support groups are well placed to address. Despite the clinical rationale for cancer-specific therapeutic bereavement groups, and some evidence that participants find them beneficial, there is little published research regarding their effectiveness. Taking part in an eight-session therapeutic group was associated with increased self-esteem and reduced role strain. Themes identified from the groups included opportunities for change, new relationships, time and rituals.
This study evaluates a new cancer bereavement therapeutic group intervention incorporating aspects of Compassion Focused Therapy (CFT), Cognitive Behavioral Therapy (CBT), Cognitive Therapy for PTSD (CT-PTSD), and self-help groups. The aim is to test whether a 7-session cancer bereavement therapeutic group is associated with changes in grief responses, psychological symptoms and self-compassion, at intervention completion and at three-month follow-up.
Who can participate?
People aged 18 or over who have experience of bereavement by cancer over 6 months ago
What does the study involve?
The study involves taking part in a therapeutic bereavement support group, which entails attending 7 sessions over 10 weeks. The groups run in the evening and are facilitated by psychologists. The groups are aimed at helping people who are bereaved by cancer to learn more about loss and how to cope with all that arises from it, as well as help them make stronger connections with those in a similar situation. The groups are free to attend, and participants are randomly allocated to one of three groups (one starting in October 2018 and two starting in January 2019). Participants are asked to complete some questionnaires before the group begins and after it ends (these take about 25 minutes), as well as before each meeting (these take about 10 minutes each time). The questionnaires are about how participants are feeling and how the group may be helping or not. They can be completed online.
What are the possible benefits and risks of participating?
Previous testing of content from the groups showed that people taking part experienced a positive impact on their grief, lower levels of depression and anxiety, and increased self-compassion. It is hoped that the information from this study will advance knowledge about the principles of cancer bereavement support groups, and improve practice to help people who join support groups in the future. It is possible that participants could feel upset when completing the questionnaires, although they cover topics that they are likely to have talked about and been supported with during the group sessions. If participants were to become upset, they could discuss this with facilitators of the group, and they will have the option of stopping participation.
Where is the study run from?
The Loss Foundation (UK)
When is the study starting and how long is it expected to run for?
August 2018 to June 2019
Who is funding the study?
1. The Loss Foundation (UK)
2. Postcode Community Trust (UK)
Who is the main contact?
Dr Erin Thompson
Contact information
Public
34b York Way
London
N1 9AB
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled longitudinal study |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A randomised controlled trial exploring outcomes of 7-session cancer bereavement therapeutic support groups for adults |
| Study objectives | The present study hypothesises that a 7-session cancer bereavement therapeutic group intervention for adults will be associated with changes in grief responses, psychological symptoms and self-compassion, at intervention completion and at 3-month follow-up. |
| Ethics approval(s) | The Chair of The Loss Foundation Board (registered number 1147362) and The Loss Foundation Research Committee, 29/08/2018, Project ID No: 180829TLF |
| Health condition(s) or problem(s) studied | Cancer bereavement |
| Intervention | Participants will be randomised using a computer randomisation tool. Participants are randomly allocated to one of three groups (one starting in October 2018 and two starting in January 2019). The 7-session therapeutic bereavement group intervention incorporates aspects of psychoeducation, Compassion Focused Therapy (CFT), Cognitive Behavioural Therapy (CBT), Cognitive Therapy for PTSD (CT-PTSD: Ehlers & Clark, 2000), and self-help groups. Groups will be run by Psychologists trained in the intervention content. Quantitative data will be collected using a range of self-report outcome measures. Specific outcome measures will be collected at the first and last sessions (pre-post), whilst others will be collected weekly. All groups will be followed up 3-months post the intervention. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
All outcome measures will be collected online using Qualtrics, a professional survey software. The following questionnaires will be collected at baseline (registering to the groups), prior to every group session, post the intervention, and at 3 months follow up: |
| Key secondary outcome measure(s) |
The following questionnaire will be collected after each group session: |
| Completion date | 30/06/2019 |
Eligibility
| Participant type(s) | Other |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 60 |
| Key inclusion criteria | 1. Aged 18 or over 2. Experience of bereavement by cancer 3. Time since bereavement greater than six months, so as not to interfere with a natural recovery process (Schut & Stroebe, 2010) 4. Not undergoing any other psychological treatment during participation in the intervention 5. Self-referral to the charity or via a related organization |
| Key exclusion criteria | Significant substance or alcohol misuse, which would interfere with ability to participate |
| Date of first enrolment | 01/09/2018 |
| Date of final enrolment | 30/09/2018 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
London
N1 9AB
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| IPD sharing plan | The data sharing plans for the current study are unknown and will be made available at a later date. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
04/06/2021: The intention to publish date has been changed from 30/06/2020 to 30/06/2022.